AeroGrow International 10-Q 12 Nov 13 2014 Q2 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	6 Months Ended
	Sep. 30, 2013	Nov. 08, 2013
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'AeroGrow International, Inc.	'
Document Type	'10-Q	'
Current Fiscal Year End Date	'--03-31	'
Entity Common Stock, Shares Outstanding	'	5,904,877
Amendment Flag	'false	'
Entity Central Index Key	'0001316644	'
Entity Current Reporting Status	'Yes	'
Entity Voluntary Filers	'No	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Well-known Seasoned Issuer	'No	'
Document Period End Date	30-Sep-13	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q2	'

CONDENSED_BALANCE_SHEETS

CONDENSED BALANCE SHEETS (USD $)	Sep. 30, 2013	Mar. 31, 2013
Current assets	'	'
Cash	$2,090,377	$524,491
Restricted cash	24,991	42,294
Accounts receivable, net of allowance for doubtful accounts of $3,505 and $1,100 at September 30, 2013 and March 31, 2013, respectively	77,424	173,096
Other receivables	57,943	168,511
Inventory	1,104,188	1,229,397
Prepaid expenses and other	500,562	204,927
Total current assets	3,855,485	2,342,716
Property and equipment, net of accumulated depreciation of $2,939,893 and $2,868,610 at September 30, 2013 and March 31, 2013, respectively	332,009	265,508
Other assets	'	'
Intangible assets, net of $364 and $134,837 of accumulated amortization at September 30, 2013 and March 31, 2013, respectively	1,811	195,403
Deposits	145,014	145,201
Deferred debt issuance costs, net of accumulated amortization of $267,030 and $254,636 at September 30, 2013 and March 31, 2013, respectively	10,658	23,052
Total other assets	157,483	363,656
Total assets	4,344,977	2,971,880
Current liabilities	'	'
Notes payable	309,250	518,347
Notes payable – related party	67,369	122,026
Current portion – long term debt	1,051,997	899,399
Accounts payable	532,262	379,242
Accrued expenses	185,804	292,066
Customer deposits	86,488	156,929
Deferred rent	5,766	6,209
Total current liabilities	2,238,936	2,374,218
Long term debt	0	1,168,711
Total liabilities	2,238,936	3,542,929
Commitments and contingencies	0	0
Stockholders' equity (deficit)	'	'
Preferred stock, $.001 par value, 20,000,000 shares authorized, 2,649,007 and 0 shares issued and outstanding at September 30, 2013 and March 31, 2013, respectively	2,649	0
Common stock, $.001 par value, 750,000,000 shares authorized, 5,904,877 and 5,904,877 shares issued and outstanding at September 30, 2013 and March 31, 2013, respectively	5,905	5,905
Additional paid-in capital	79,058,939	75,427,217
Accumulated deficit	-76,961,452	-76,004,171
Total stockholders' equity (deficit)	2,106,041	-571,049
Total liabilities and stockholders' equity (deficit)	$4,344,977	$2,971,880

CONDENSED_BALANCE_SHEETS_Paren

CONDENSED BALANCE SHEETS (Parentheticals) (USD $)	Sep. 30, 2013	Mar. 31, 2013
Allowance for doubtful accounts (in Dollars)	$3,505	$1,100
Accumulated depreciation (in Dollars)	2,939,893	2,868,610
Accumulated amortization of intangible assets (in Dollars)	364	134,837
Accumulated amortization of deferred debt issuance costs (in Dollars)	$267,030	$254,636
Preferred stock, par value (in Dollars per share)	$0.00	$0.00
Preferred stock, shares authorized (in Shares)	20,000,000	20,000,000
Preferred stock, shares issued (in Shares)	2,649,007	0
Preferred stock, shares outstanding (in Shares)	2,649,007	0
Common stock, par value (in Dollars per share)	$0.00	$0.00
Common stock, shares authorized (in Shares)	750,000,000	750,000,000
Common stock, shares issued (in Shares)	5,904,877	5,904,877
Common stock, shares outstanding (in Shares)	5,904,877	5,904,877

CONDENSED_STATEMENTS_OF_OPERAT

CONDENSED STATEMENTS OF OPERATIONS (Unaudited) (USD $)	3 Months Ended		6 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Product sales	$676,035	$1,144,260	$1,799,204	$2,560,793
Cost of revenue	388,405	545,868	1,109,849	1,239,200
Gross profit	287,630	598,392	689,355	1,321,593
Operating expenses	'	'	'	'
Research and development	33,569	115,114	55,238	208,138
Sales and marketing	394,199	432,061	864,220	883,238
General and administrative	381,321	439,674	780,552	1,017,290
Total operating expenses	809,089	986,849	1,700,010	2,108,666
Loss from operations	-521,459	-388,457	-1,010,655	-787,073
Other (income) expense, net	'	'	'	'
Fair value changes in derivative warrant liability	12,321	0	12,321	0
Interest (income)	-2	-2	-4	-4
Interest expense	101,546	103,814	192,713	212,789
Interest expense – related party	2,860	4,444	6,453	16,094
Debt conversion cost	0	0	0	6,648,267
Other (income)	-16,357	-98,059	-533,014	-97,757
Total other (income) expense, net	100,368	10,197	-321,531	6,779,389
Net loss	-621,827	-398,654	-689,124	-7,566,462
Deemed dividend on convertible preferred stock	0	0	-268,157	0
Net loss attributable to common shareholders	($621,827)	($398,654)	($957,281)	($7,566,462)
Net loss per share, basic and diluted (in Dollars per share)	($0.11)	($0.07)	($0.12)	($1.31)
Weighted average number of common shares outstanding, basic and diluted (in Shares)	5,904,877	5,809,545	5,904,877	5,786,606

CONDENSED_STATEMENTS_OF_CASH_F

CONDENSED STATEMENTS OF CASH FLOWS (USD $)	6 Months Ended		138 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013
Cash flows from operating activities:	'	'	'
Net (loss)	($689,124)	($7,566,462)	($76,961,452)
Adjustments to reconcile net (loss) to cash (used) provided by operations:	'	'	'
Issuance of common stock and options under equity compensation plans	87,062	124,791	'
Issuance of common stock and options not under equity compensation plans	0	3	'
Depreciation and amortization expense	71,139	70,477	'
Bad debt expense	2,395	-778	'
Loss on disposal of fixed assets	71	0	'
Fair value remeasurement of derivative warrant liability	12,321	0	'
Accretion of debt associated with sale of intellectual property	-22,118	0	'
Gain on the forgiveness of debt	-488,625	0	'
Debt conversion costs associated with inducement	0	3,461,637	'
Amortization of debt issuance costs	12,394	847,574	'
Amortization of convertible debentures, beneficial conversion feature	0	1,066,804	'
Amortization of convertible debentures, beneficial conversion feature – related party	0	188,924	'
Interest expense from warrants issued with convertible debentures	0	954,687	'
Interest expense from warrants issued with convertible debentures – related party	0	186,881	'
Change in operating assets and liabilities:	'	'	'
Decrease in accounts receivable	93,277	176,687	'
Decrease in other receivable	110,568	96,874	'
(Increase) in inventory	-111,929	-345,961	'
(Increase) in other current assets	-295,635	-293,992	'
Decrease in deposits	187	543	'
Increase (decrease) in accounts payable	153,020	-223,278	'
Decrease in accrued expenses	-106,262	-5,479	'
Increase in accrued interest	39,454	71,450	'
Increase in accrued interest-related party	6,453	13,260	'
Decrease in customer deposits	-70,441	-7,378	'
Increase (decrease) in deferred rent	-443	760	'
Net cash (used) provided by operating activities	-1,196,236	-1,181,976	'
Cash flows from investing activities:	'	'	'
Decrease (increase) in restricted cash	17,303	-2,576	'
Purchases of equipment	-138,079	-14,546	'
Patent expenses	0	-10,162	'
Proceeds from the sale of intellectual property	500,000	0	'
Net cash provided (used) by investing activities	379,224	-27,284	'
Cash flows from financing activities:	'	'	'
(Increase) in prepaid debt issuance costs	0	-46,129	'
Proceeds from notes payable, net	0	1,040,722	'
Proceeds from notes payable – related party, net	0	245,000	'
Repayments of notes payable	-245,636	-442,701	'
Repayments of notes payable – related party	-54,207	-187,849	'
Repayments of long term debt borrowings	-1,159,944	-161,009	'
Proceeds from the issuance of preferred stock	4,000,000	0	'
Payments for offering costs of preferred stock	-157,315	0	'
Proceeds from the exercise and issuance of warrants	0	1,180,898	'
Net cash provided by financing activities	2,382,898	1,628,932	'
Net increase in cash	1,565,886	419,672	'
Cash, beginning of period	524,491	501,577	'
Cash, end of period	2,090,377	921,249	2,090,377
Interest	36,852	59,153	'
Income taxes	0	0	'
Supplemental disclosure of non-cash investing and financing activities:	'	'	'
Deemed dividend on convertible preferred stock	268,157	0	'
Decrease of inventory associated with debt settlement	237,138	0	'
Fair value of warrant liability	575,854	0	'
Fair value of warrant issue to placement agent	107,500	0	'
Debt associated with sale of intellectual property	284,206	0	'
Decrease of debt associated with inventory consumption	0	138,399	'
Issuance of common stock in accordance with credit card note	0	176,786	'
Conversion of accrued expenses to common stock	0	28,086	'
Conversion of Note Payable to common stock [Member]	'	'	'
Supplemental disclosure of non-cash investing and financing activities:	'	'	'
Conversion of Debt to Common Stock	0	211,690	'
Conversion of Note Payable - related party to common stock [Member]	'	'	'
Supplemental disclosure of non-cash investing and financing activities:	'	'	'
Conversion of Debt to Common Stock	0	129,258	'
Conversion of convertible note to common stock [Member]	'	'	'
Supplemental disclosure of non-cash investing and financing activities:	'	'	'
Conversion of Debt to Common Stock	0	5,717,882	'
Conversion of convertible note accrued interest to common stock [Member]	'	'	'
Supplemental disclosure of non-cash investing and financing activities:	'	'	'
Conversion of Debt to Common Stock	0	545,157	'
Conversion of convertible note-related party to common stock [Member]	'	'	'
Supplemental disclosure of non-cash investing and financing activities:	'	'	'
Conversion of Debt to Common Stock	0	1,078,513	'
Conversion of convertible note-related party accrued interest to common stock [Member]	'	'	'
Supplemental disclosure of non-cash investing and financing activities:	'	'	'
Conversion of Debt to Common Stock	$0	$102,828	'

1_Description_of_the_Business

1. Description of the Business	6 Months Ended
	Sep. 30, 2013
Disclosure Text Block [Abstract]	'
Basis of Accounting [Text Block]	'
	1.	Description of the Business
	AeroGrow International, Inc. (the “Company," “we,” “AeroGrow,” or “our”) was formed as a Nevada corporation on March 25, 2002. The Company’s principal business is developing, marketing, and distributing advanced indoor aeroponic garden systems designed and priced to appeal to the consumer gardening, cooking and small indoor appliance markets worldwide.  The Company’s principal activities from its formation through March 2006 consisted of product research and development, market research, business planning, and raising the capital necessary to fund these activities. In December 2005, the Company commenced pilot production of its AeroGarden system and, in March 2006, began shipping these systems to retail and catalogue customers. The Company manufactures, distributes and markets five different models of its AeroGarden systems in multiple colors, as well as over 40 varieties of seed kits and a full line of accessory products through multiple channels including retail, catalogue and direct-to-consumer sales primarily in the United States and Canada, as well as selected countries in Europe, Asia and Australia.

2_Liquidity_and_Basis_of_Prese

2. Liquidity and Basis of Presentation	6 Months Ended
	Sep. 30, 2013
Disclosure Text Block [Abstract]	'
Basis of Presentation and Significant Accounting Policies [Text Block]	'
	2.	Liquidity and Basis of Presentation
	Interim Financial Information
	The unaudited interim financial statements of the Company included herein have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim reporting including the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. These condensed statements do not include all disclosures required by accounting principles generally accepted in the United States of America (“U.S. GAAP”) for annual audited financial statements and should be read in conjunction with the Company’s audited financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended March 31, 2013, as filed with the SEC on July 1, 2013.
	In the opinion of management, the accompanying unaudited interim financial statements reflect all adjustments, including normal recurring adjustments, necessary to present fairly the financial position of the Company at September 30, 2013, the results of operations for the three and six months ended September 30, 2013 and 2012, and the cash flows for the six months ended September 30, 2013 and 2012. The results of operations for the three and six months ended September 30, 2013 are not necessarily indicative of the expected results of operations for the full year or any future period. In this regard, the Company’s business is highly seasonal, with approximately 49.3% of revenues in the fiscal year ended March 31, 2013 (“Fiscal 2013”) occurring in the four consecutive calendar months (October – January).  Furthermore, during the six-month period ended September 30, 2013, the Company has curtailed sales and incurred additional product and marketing expenses while it rebrands inventory and advertising materials with the Miracle-Gro trade name.  The balance sheet as of March 31, 2013 is derived from the Company’s audited financial statements.
	The Company has incurred net losses since its inception, including a net loss for the six months ended September 30, 2013, of $76,961,452.
	Sources of funding to meet prospective cash requirements include the Company’s existing cash balances, cash flow from operations, and borrowings under the Company’s debt arrangements.
	In the fiscal year ended March 31, 2012 (“Fiscal 2012”), we recapitalized our balance sheet.  Specifically, we restructured the amounts and payment timing of certain of our accounts payable, issued $1.6 million in short-term working capital debt,  restructured the payment schedule for a $2.1 million note payable to a supplier, and received approval from our shareholders and affected creditors to convert our Series A Convertible Preferred Stock and Subordinated Secured Convertible Notes into common stock. The conversions of our convertible securities were completed in April 2012, the first month of (“Fiscal 2013”).  In addition, during the first quarter of Fiscal 2013, we offered our warrant holders the opportunity to exercise their warrants at a reduced price, resulting in $1.59 million of new common equity capital from warrant exercises.
	In April 2013, we entered into a Securities Purchase Agreement and strategic alliance with a wholly owned subsidiary of The Scotts Miracle-Gro Company (NYSE:  SMG, “Scotts Miracle-Gro”).  Pursuant to the Securities Purchase Agreement, we issued (i) 2,649,007 shares of Series B Convertible Preferred Stock, par value $0.001 per share (the “Series B Preferred Stock); and (ii) a warrant to purchase shares of our common stock for an aggregate purchase price of $4.0 million.  As part of the strategic alliance, we also entered into several other agreements with Scotts Miracle-Gro, including: (i) an Intellectual Property Sale Agreement; (ii) a Technology Licensing Agreement; (iii) a Brand License Agreement; and (iv) a Supply Chain Management Agreement.
	In the Intellectual Property Agreement, we agreed to sell all intellectual property associated with our hydroponic products (the “Hydroponic IP”), other than the AeroGrow and AeroGarden trademarks, free and clear of all encumbrances, to Scotts Miracle-Gro for $500,000.  Scotts Miracle-Gro has the right to use the AeroGrow and AeroGarden trademarks in connection with the sale of products incorporating the Hydroponic IP.  In addition to the working capital infusion of approximately $4.5 million from the Securities Purchase Agreement and Intellectual Property Sale Agreement, the strategic alliance affords us the use of the globally recognized and highly trusted Miracle-Gro brand name.  We believe that the strategic alliance also gives Scotts Miracle-Gro an entry into the burgeoning indoor gardening market, while providing AeroGrow a broad base of support in marketing, distribution, supply chain logistics, R&D, and material sourcing.  We intend to use our strategic alliance with Scotts Miracle-Gro to re-establish our presence in the retail and international sales channels.
	As a result of these efforts, we believe we can meet our cash requirements for the next twelve months.  We may need to seek additional capital, however, to provide a cash reserve against contingencies, address the seasonal nature of our working capital needs, and to enable us to invest further in trying to increase the scale of our business.  There can be no assurance we will be able to raise this additional capital, that we will be able to increase the scale of our business, or that our existing resources will be sufficient to meet all of our cash requirements.  In such an event, we would reduce the scale of our operations and take such actions as are available to us to reduce our cash requirements.  However, there can be no assurance that such actions would be successful.
	Significant Accounting Policies
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.  It is reasonably possible that a change in the Company’s estimates will occur in the near term.
	Net Income (Loss) per Share of Common Stock
	The Company computes net income (loss) per share of common stock in accordance with Accounting Standards Codification (“ASC”) 260.  ASC 260 requires companies with complex capital structures to present basic and diluted Earnings per Share (“EPS”).  Basic EPS is measured as the income or loss available to common stockholders divided by the weighted average shares of common stock outstanding for the period. Diluted EPS is similar to basic EPS but presents the dilutive effect on a per share basis of potential common stock (e.g., convertible securities, options, and warrants) as if they had been converted at the beginning of the periods presented. Potential shares of common stock that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS.  All potentially dilutive securities outstanding have been excluded for the periods presented since their effect would be antidilutive.
	Reclassifications
	Certain prior year amounts have been reclassified to conform to current year presentation.
	Concentrations of Risk
	ASC 825-10-50-20 requires disclosure of significant concentrations of credit risk regardless of the degree of such risk.  Financial instruments with significant credit risk include cash deposits.  The amount on deposit with one financial institution exceeded the $250,000 federally insured limit as of September 30, 2013.  However, management believes that the financial institution is financially sound and the risk of loss is minimal.
	Customers:
	For the three months ended September 30, 2013, the Company had two customers, Amazon.com and Canadian Tire Company, that represented 27.0% and 11.6% of sales, respectively.  For the three months ended September 30, 2012, the Company had no customers that represented more than 5.0% of the Company’s net product sales. For the six months ended September 30, 2013, the Company had one customer, Amazon.com, that represented 18.0% of the Company’s net product sales. For the six months ended September 30, 2012, the Company had no customers that represented more than 5.0% of the Company’s net product sales.
	Suppliers:
	For the three months ended September 30, 2013, the Company purchased inventories and other inventory-related items from four suppliers totaling $488,801, $194,153, $64,926 and $43,822, representing 125.8%, 50.0%, 16.7% and 11.3% of cost of revenue, respectively. For the three months ended September 30, 2012, the Company purchased inventories and other inventory-related items from four suppliers totaling $237,690, $137,871, $82,846 and $79,251, representing 43.5%, 25.3%, 15.2% and 14.5% of cost of revenue, respectively. For the six months ended September 30, 2013, the Company purchased inventories and other inventory-related items from four suppliers totaling $530,124, $284,767, $92,659 and $64,926, representing 47.8%, 25.7%, 8.3% and 5.9% of cost of revenue, respectively. For the six months ended September 30, 2012, the Company purchased inventories and other inventory-related items from four suppliers totaling $325,209, $284,045, $137,677, and $118,733, representing 26.2%, 22.9%, 11.1% and 9.6% of cost of revenue, respectively.
	The Company’s primary contract manufacturers are located in China.  As a result, the Company may be subject to political, currency, regulatory and weather/natural disaster risks.  Although the Company believes alternate sources of manufacturing could be obtained, these risks could have an adverse impact on our operations.
	Accounts Receivable:
	As of September 30, 2013, the Company had three customers that represented 66.0%, 10.3% and 5.0% of the Company’s outstanding accounts receivable.  As of March 31, 2013, the Company had one customer who represented 61.2% of outstanding accounts receivable.  The Company believes that all receivables from these customers are collectible.
	Fair Value of Financial Instruments
	The Company follows the guidance in ASC 820, Fair Value Measurements and Disclosures (“ASC 820”), as it relates to the fair value of its financial assets and liabilities. ASC 820 provides for a standard definition of fair value to be used in new and existing pronouncements. This guidance requires disclosure of fair value information about certain financial instruments (insurance contracts, real estate, goodwill and taxes are excluded) for which it is practicable to estimate such values, whether or not these instruments are included in the balance sheet at fair value. The fair values presented for certain financial instruments are estimates which, in many cases, may differ significantly from the amounts that could be realized upon immediate liquidation.
	Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability, i.e., exit price, in an orderly transaction between market participants.  ASC 820 also provides a hierarchy for determining fair value, which emphasizes the use of observable market data whenever available. The three broad levels defined by the hierarchy are as follows, with the highest priority given to Level 1 as these are the most reliable, and the lowest priority given to Level 3.
	Level 1 – Quoted prices in active markets for identical assets.
	Level 2 – Quoted prices for similar assets in active markets, quoted prices for identical or similar assets in markets that are not active, or other inputs that are observable or can be corroborated by observable market data, including model-derived valuations.
	Level 3 – Unobservable inputs that are supported by little or no market activity.
	The carrying value of financial instruments including receivables, accounts payable and accrued expenses, approximates their fair value at September 30, 2013 and March 31, 2013 due to the relatively short-term nature of these instruments. As of September 30, 2013 and March 31, 2013, the fair value of the Company's debt, notes payable, and sale of intellectual property liability using Level 3 inputs was estimated using the discounted cash flow method, which is based on the future expected cash flows, discounted to their present values, using a discount rate of 15%.
	In conjunction with the Securities Purchase Agreement and strategic alliance Scotts Miracle-Gro, the Company issued a warrant that entitles, but does not obligate, Scotts Miracle-Gro to purchase a number of shares of common stock that, on a fully diluted basis, constitute 80% of the Company’s outstanding capital stock. This warrant was accounted for as a liability at its estimated fair value. The Company calculated the fair value of the warrant during the quarter ended September 30, 2013 using a multiple based valuation model.
			30-Sep-13				31-Mar-13
			Fair Value		Carry Value		Fair Value		Carry Value
	Liabilities
	Notes payable		$	295,616	$	376,619	$	610,417	$	640,373
	Sale of Intellectual Property Liability			182,023		284,206		--		--
	Warrant Liability			575,854		575,854		--		--
	Long-term debt			183,542		191,937		1,725,513		2,068,110
	Total		$	1,237,035	$	1,428,616	$	2,335,930	$	2,708,483
	As of September 30, 2013, the Company measured the warrant at fair value and will continue to do so on a recurring basis subsequent to initial recognition. As of March 31, 2013, the Company did not have any financial assets or liabilities that were measured at fair value on a recurring basis subsequent to initial recognition.
	Accounts Receivable and Allowance for Doubtful Accounts
	The Company sells its products to retailers and consumers. Consumer transactions are primarily paid by credit card.  Retailer sales terms vary by customer, but generally range from net 30 days to net 90 days.  Accounts receivable are reported at net realizable value and net of the allowance for doubtful accounts. The Company uses the allowance method to account for uncollectible accounts receivable. The Company's allowance estimate is based on a review of the current status of trade accounts receivable, which resulted in an allowance of $3,505 and $1,100 at September 30, 2013 and March 31, 2013, respectively.
	Other Receivables
	In conjunction with the Company’s processing of credit card transactions for its direct-to-consumer sales activities and as security with respect to the Company’s performance for credit card refunds and charge backs, the Company is required to maintain a cash reserve with Litle and Company, the Company’s credit card processor. This reserve is equal to 5% of the credit card sales processed during the previous six months. As of September 30, 2013 and March 31, 2013, the balance in this reserve account was $57,943 and $168,511, respectively.
	Advertising and Production Costs
	The Company expenses all production costs related to advertising, including print, television, and radio advertisements when the advertisement has been broadcast or otherwise distributed.  The Company records media costs related to its direct-to-consumer advertisements, inclusive of postage and printing costs incurred in conjunction with mailings of direct-response catalogues, and related direct-response advertising costs, in accordance with ASC 340-20-Reporting on Advertising Costs.  As prescribed by ASC 340-20-25, direct response advertising costs incurred are reported as assets and are amortized over the estimated period of the benefits, based on the proportion of current period revenue from the advertisement to probable future revenue.  As of September 30, 2013 and March 31, 2013, the Company deferred $1,198 and $3,799, respectively, related to such media and advertising costs. Advertising expenses for the three months ended September 30, 2013 and September 30, 2012 were $42,513 and $120,260, respectively. Advertising expenses for the six months ended September 30, 2013 and September 30, 2012 were $118,339 and $290,717, respectively.
	Inventory
	Inventories are valued at the lower of cost, determined by the first-in, first-out method, or market.  Included in inventory costs where the Company is the manufacturer are raw materials, labor, and manufacturing overhead. The Company records the raw materials at delivered cost. Standard labor and manufacturing overhead costs are applied to the finished goods based on normal production capacity as prescribed under ASC 330 Inventory Pricing.  A majority of the Company’s products are manufactured overseas and are recorded at cost.
			September 30,		March 31,
			2013		2013
	Finished goods		$	726,639	$	606,101
	Raw materials			377,549		623,296
			$	1,104,188	$	1,229,397
	The Company determines an inventory obsolescence reserve based on management’s historical experience and establishes reserves against inventory according to the age of the product. As of September 30, 2013 and March 31, 2013, the Company had reserved $331,552 for inventory obsolescence.
	Revenue Recognition
	The Company recognizes revenue from product sales, net of estimated returns, when persuasive evidence of a sale exists: that is, a product is shipped under an agreement with a customer; risk of loss and title has passed to the customer; the fee is fixed or determinable; and collection of the resulting receivable is reasonably assured.
	The Company records estimated reductions to revenue for customer and distributor programs and incentive offerings, including promotions, rebates, and other volume-based incentives.  Certain incentive programs require the Company to estimate based on industry experience the number of customers who will actually redeem the incentive. As of September 30, 2013 and March 31, 2013, the Company had accrued $42,880 and $42,623, respectively, as its estimate for the foregoing deductions and allowances.
	Warranty and Return Reserves
	The Company records warranty liabilities at the time of sale for the estimated costs that may be incurred under its basic warranty program. The specific warranty terms and conditions vary depending upon the product sold but generally include technical support, repair parts, and labor for periods up to one year. Factors that affect the Company’s warranty liability include the number of installed units currently under warranty, historical and anticipated rates of warranty claims on those units, and cost per claim to satisfy the Company’s warranty obligation.  Based upon the foregoing, the Company has recorded a provision for potential future warranty costs of $8,313 and $9,514 as of September 30, 2013 and March 31, 2013, respectively.
	The Company reserves for known and potential returns from customers and associated refunds or credits related to such returns based upon historical experience. In certain cases, retailer customers are provided a fixed allowance, usually in the 1% to 2% range, to cover returned goods and this allowance is deducted from payments made to us by such customers. As of September 30, 2013 and March 31, 2013, the Company has recorded a reserve for customer returns of $10,576 and $27,255, respectively.
Recently Issued Accounting Pronouncements
In July 2013, the FASB issued ASU 2013-11, “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists,” which among other things, require an unrecognized tax benefit, or a portion of an unrecognized tax benefit, to be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, except as denoted within the ASU. The amendments in this ASU are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. This new guidance will not have a material impact on our financial statements.

3_Notes_Payable_Long_Term_Debt

3. Notes Payable, Long Term Debt and Current Portion - Long Term Debt	6 Months Ended
	Sep. 30, 2013
Debt Disclosure [Abstract]	'
Debt Disclosure [Text Block]	'
	3.	Notes Payable, Long Term Debt and Current Portion – Long Term Debt
	As of September 30, 2013 and March 31, 2013, the outstanding balance of the Company’s note payable and debt, including accrued interest, is as follows:
			September 30,		March 31,
			2013		2013
	Main Power Promissory Note		$	--	$	1,703,764
	First Western Trust Term Loan			156,557		322,832
	Notes Payable – Credit Card Receipts-Backed Notes			376,620		640,373
	Pawnee Promissory Note			35,379		41,514
	Debt Associated with Scotts Miracle-Gro Transaction  (see Note 4)			860,060		-
	Total Debt			1,428,616		2,708,483
	Less Notes Payable and Current Portion – Long Term Debt			1,428,616		1,539,772
	Long Term Debt		$	--	$	1,168,711
	Main Power Promissory Note
	On June 30, 2009, the Company entered into a Letter Agreement (“Letter Agreement”) with Main Power Electrical Factory, Ltd. (“Main Power”) and executed a Promissory Note.  Pursuant to the terms of the Letter Agreement, Main Power agreed to release the Company from $1,386,041 of existing obligations owed by the Company to Main Power in return for the execution of the Promissory Note for the same amount.  In addition, the Letter Agreement included other provisions relating to the terms and conditions under which AeroGrow purchases AeroGarden products from Main Power.  The original Promissory Note had a final maturity of June 30, 2011, carried an interest rate of 8% per annum and called for principal payments of $150,000 monthly beginning January 31, 2011, with a final payment of all principal and accrued but unpaid interest due on June 30, 2011.
	Effective as of December 31, 2010, AeroGrow and Main Power entered into an agreement to amend various obligations owed by AeroGrow to Main Power.  As part of the amendments, AeroGrow issued a new promissory note (the “Revised Main Power Note”) in the amount of $2,162,046.  The Revised Main Power Note retired and replaced the original Promissory Note, and also retired and replaced certain obligations totaling $661,446 relating to raw material and finished goods inventory purchased and/or manufactured by Main Power on behalf of AeroGrow.  The Revised Main Power Note had a final maturity of May 31, 2013, and carried an interest rate of 8% per annum.
	During the quarter ended June 30, 2011, AeroGrow fell behind on the scheduled payments due under the Revised Main Power Note because of its cash constraints and reached an informal arrangement with Main Power to defer payments while a restructuring of the note was negotiated. Subsequently, the parties executed an amendment to the Revised Main Power Note that, effective as of December 31, 2011, restructured the amortization schedule for the Revised Main Power Note and extended the final maturity to December 15, 2015.  In addition, Main Power agreed to waive any existing defaults under the Revised Main Power Note.  The agreed revisions to the amortization schedule provided for monthly interest payments through the final maturity and principal payments totaling $3,000 during the fourth fiscal quarter of Fiscal 2012, $159,000 during Fiscal 2013, $555,000 during the fiscal year ending March 31, 2014, $725,000 during the fiscal year ending March 31, 2015, and $664,724 during the period April 2015 through December 2015.  In addition, any utilization by AeroGrow of consignment inventory held as collateral by Main Power further reduced the amount outstanding under the Revised Main Power Note.  On April 23, 2013, the MainPower Promissory Note outstanding, including all accrued interest, was paid in full for $950,000.  As of April 23, 2013, there was $237,138 in consignment inventory held by Main Power that was fully reserved for during the three month period ending June 30, 2013. The inventory reserve combined with the payment in full resulted in a net gain of $488,625 recognized in other income and expense for the six months ended September 30, 2013.
	First Western Trust Term Loan
	On May 21, 2010, the Company, First Western Trust Bank (“FWTB”) and Jack J. Walker, our Chairman, as guarantor, executed a business loan agreement and related promissory note (the “FWTB Term Loan”) for a four-year loan in an initial principal amount of $1 million.  The FWTB Term Loan is secured by a lien on our assets and bears interest at a fixed rate of 7.25% per annum.  We make equal monthly payments of principal/interest over the four-year term of the FWTB Term Loan, which has a final maturity date of May 21, 2014.  The terms and conditions of the FWTB Term Loan include limitations on the Company incurring additional debt and paying dividends on our stock without the consent of FWTB.  In the event of a default under the FWTB Term Loan, FWTB has the option to declare the loan immediately due and payable.  As of September 30, 2013, $156,557 was outstanding under the FWTB Term Loan, including accrued interest and we were current and in compliance with all terms and conditions.
	Notes Payable – 2011 Credit Card Receipts-Backed Notes
	During the three months ended December 31, 2011, we closed on the private sale of $1,633,776 in 17% secured promissory notes backed by a portion of our prospective credit card receipts, (the “2011 Credit Card Notes”) and a 1% share of our prospective monthly sales into the network marketing channel for a period of three years following our first sale into the network marketing channel (the “MLM Revenue Share”) (collectively, the “2011 Credit Card Offering”).  Consideration for the 2011 Credit Card Offering comprised $1,477,300 in cash and the conversion of $156,476 in other obligations of the Company, including $61,476 of deferred compensation owed to executive officers of the Company.  After deducting $46,565 of placement agent sales commissions (5% on third-party investors, 3% on Company-referred investors and 0% on investments by officers and directors of the Company) and expenses, net cash proceeds to the Company totaled $1,430,735.  In addition, the Company is obligated to pay a deferred sales commission to the placement agent equal to 10% of the MLM Revenue Share paid to investors in the 2011 Credit Card Offering (with the deferred sales commission reduced to 6% for payments to Company-referred investors and 0% on payments to officers and directors), concurrently with the payment of the MLM Revenue Share.
	We used the proceeds from the 2011 Credit Card Offering to invest in advertising and marketing programs to support our direct-to-consumer business, purchase inventory, provide other general working capital, and pay commissions and expenses related to the private offering.  The issuance of the 2011 Credit Card Offering was conducted in reliance upon exemptions from registration requirements under the Securities Act, including, without limitation, those under Rule 506 of Regulation D (as promulgated under the Securities Act).  The 2011 Credit Card Offering was offered and sold only to investors who are, or the Company reasonably believed to be, “accredited investors,” as defined in Rule 501(a) of Regulation D under the Securities Act.  Because the 2011 Credit Card Offering has not been registered under the Securities Act, the securities sold in the 2011 Credit Card Offering are “restricted securities” within the meaning of Rule 144 under the Securities Act, and investors will not be able to sell the securities in the United States absent an effective registration statement or an applicable exemption from registration.
	The 2011 Credit Card Notes bore interest at 17% per annum and had a final maturity of October 1, 2012.  20% of our daily credit card receipts were held in escrow with First Western Trust Bank under an Escrow and Account Control Agreement to fund bi-weekly payments of principal and interest to the investors in the Credit Card Offering.
	The obligation of the Company to repay the Credit Card Notes was severally guaranteed by Jack J. Walker, our Chairman (up to $510,555), J. Michael Wolfe, our Chief Executive Officer (up to $204,222) and H. MacGregor Clarke, our former Chief Financial Officer (up to $102,111).
	During May 2012, $340,948 in 2011 Credit Card Notes (including accrued interest) were effectively repaid when note holders elected to offset the $340,948 balance due against payment of the exercise price on outstanding stock warrants.
	As of September 13, 2012, the remaining balance and accrued interest on the 2011 Credit Card Notes were repaid in full.
	Notes Payable – 2012 Credit Card Receipts-Backed Notes
	On September 14, 2012, the Company closed on the private sale of $1,285,722 in Series 2012CC 15% secured promissory notes backed by a portion of the Company’s prospective credit card receipts, (the “2012 Credit Card Notes”) and 128,573 shares of common stock (collectively, the “2012 Credit Card Offering”).  Consideration for the 2012 Credit Card Offering comprised $1,285,722 in cash.  After deducting $46,128 of placement agent sales commissions (5% on third-party investors, 3% on Company-referred investors and 0% on investments by officers and directors of the Company) and expenses, net cash proceeds to the Company totaled $1,239,594.   In addition, the Company will issue 12,858 shares of common stock to the placement agent as additional sales compensation, representing one share of common stock for every 10 shares issued to investors in the 2012 Credit Card Offering.
	The Company used the proceeds from the 2012 Credit Card Offering to invest in advertising and marketing programs to support its direct-to-consumer business, purchase inventory, provide other general working capital, repay $198,406 of the 2011 Credit Card Notes (including accrued interest) and pay commissions and expenses related to the private offering.  The issuance of the 2012 Credit Card Offering was conducted in reliance upon exemptions from registration requirements under the Securities Act of 1933 (the “Securities Act”), including, without limitation, those under Rule 506 of Regulation D (as promulgated under the Securities Act).  The 2012 Credit Card Offering was offered and sold only to investors who are, or the Company reasonably believed to be, “accredited investors,” as defined in Rule 501(a) of Regulation D under the Securities Act.  Because the 2012 Credit Card Offering has not been registered under the Securities Act, the securities sold in the 2012 Credit Card Offering are “restricted securities” within the meaning of Rule 144 under the Securities Act, and investors will not be able to sell the securities in the United States absent an effective registration statement or an applicable exemption from registration.
	Directors and officers of the Company invested $245,000 in the 2012 Credit Card Offering and were issued 2012 Credit Card Notes with a face amount of $245,000 and 24,500 shares of common stock.  Investors having a beneficial ownership in the Company of more than 5% who are not also directors or officers of the Company invested $350,000 in the 2012 Credit Card Offering and were issued 2012 Credit Card Notes with a face amount of $350,000 and 35,000 shares of common stock.  The investments by the directors, officers, and investors having a beneficial ownership in the Company of more than 5%, were on the same terms and conditions as all other investors in the 2012 Credit Card Offering.
	The 2012 Credit Card Notes bear interest at 15% per annum and have a final maturity of November 1, 2013.  As of October 30, 2013, the 2012 Credit Card Notes final maturity was extended to January 31, 2014, by all the investors.  20% of the Company’s daily credit card receipts will be held in escrow with First Western Trust Bank under an Escrow and Account Control Agreement to fund bi-weekly payments of principal and interest to the investors in the 2012 Credit Card Offering.
	As of September 30, 2013, $376,620 was outstanding under the 2012 Credit Card Notes, including accrued interest and we were current and in compliance with all terms and conditions.
	Pawnee Lease Promissory Note
	On November 30, 2011, the Company executed a promissory note (the “Lease Promissory Note”) in the principal amount of $116,401 in favor of Pawnee Properties, LLC (“Pawnee”).  The Lease Promissory Note details the terms and conditions pursuant to which the Company will pay to Pawnee past due rent and building operating expenses related to our headquarters lease.  The Lease Promissory Note carries an interest rate of 6% per annum for the first twelve months, and 8% per annum thereafter.  Payments of principal and interest are due on the first day of each month during the periods: (i) December 2011 through April 2012 (aggregate payments for the period of $45,000); (ii) November 2012 through April 2013 (aggregate payments for the period of $45,000); and (iii) November 2013 through March 2014 (aggregate payments for the period of $36,064, which amount will be reduced by $4,500 in the event that all payments due during the term of the Lease Promissory Note are made on a timely basis).  The Lease Promissory Note can be prepaid at any time, at the option of the Company, without penalty.  In the event of a default in payment, the interest rate would be increased to 15% per annum and Pawnee would have the option to (i) declare the Lease Promissory Note to be immediately payable, or (ii) add the accrued interest to the principal balance.  As of September 30, 2013, the outstanding balance of the Lease Promissory Note, including accrued interest, was $35,379 and we were current and in compliance with all terms and conditions.
	Debt Associated with Scotts Miracle-Gro Transaction
	On April 22, 2013, the Company issued Series B Convertible Preferred Stock to a wholly-owned subsidiary of Scotts Miracle-Gro.  Pursuant to generally accepted accounting principles, the Company has classified the warrant as a liability at its estimated fair value.  The warrant liability will be re-measured to fair value, on a recurring basis, at the end of each reporting period it is exercised or expires.
	In conjunction with the Private Offering described above, the Company and Scotts Miracle-Gro also agreed to enter an Intellectual Property Sale Agreement, a Technology License Agreement, a Brand License Agreement, and a Supply Chain Services Agreement.  The Intellectual Property Sale Agreement and the Technology License constitute an agreement of sales of future revenues. Since the Company received cash from Scotts Miracle-Gro and agreed to pay for a defined period a specified percentage of the revenue, and the Company has significant involvement in the generation of the revenue, the excess paid over net book value is classified as debt and is being amortized under the effective interest method.  As of September 30, 2013, $284,206 was recorded as debt on the condensed balance sheets.

4_Scotts_MiracleGro_Transactio

4. Scotts Miracle-Gro Transactions - Convertible Preferred Stock, Warrants and Other Transactions	6 Months Ended
	Sep. 30, 2013
Disclosure Text Block Supplement [Abstract]	'
Preferred Stock [Text Block]	'
	4.	Scotts Miracle-Gro Transactions – Convertible Preferred Stock, Warrants and Other Transactions
	Series B Convertible Preferred Stock and Related Transactions
	On April 22, 2013, the Company entered into a Securities Purchase Agreement with Scotts Miracle-Gro.  Pursuant to the Securities Purchase Agreement, Scotts Miracle-Gro acquired 2,649,007 shares of the Company’s Series B Convertible Preferred Stock, par value $0.001 per share (the “Series B Preferred Stock”), and (ii) a warrant to purchase shares of the Company’s common stock (the “Warrant,” as described in greater detail below) for an aggregate purchase price of $4,000,000.  After deducting offering expenses, including commissions and expenses paid to the Company’s advisor, net cash proceeds totaled to $3,842,685.  The Company used $950,000 of the net proceeds to repay “in full” (with concessions) the Promissory Note due to Main Power.  The Company plans to use the remaining net proceeds for working capital and general corporate purposes.
	The Company also issued a warrant to purchase 125,000 shares of the Company’s common stock to the placement agent.  This warrant has an exercise price of $1.54 per share (125% of the average closing price of the Company’s common stock during the five-day period prior to the April 22, 2013 closing date). The value of this warrant was estimated at $107,500, based on the Black-Scholes model with a stock price of $1.30, calculated exercise price of $1.54, expected life of three years, annualized volatility of 117.2% and a discount rate of 0.39%. The value of the warrant was recorded as stock issuance costs.
	The Series B Preferred Stock is convertible into 2,649,007 shares of the Company’s common stock ($4,000,000 divided by a conversion price of $1.51 per share).  The Series B Preferred Stock bears a cumulative annual dividend of 8.0%, payable in shares of the Company’s common stock at a conversion price of $1.51 per share (subject to customary anti-dilution rights, as described in the Series B Preferred Stock Certificates of Designations).  The Series B Preferred Stock does not have a liquidation preference and shall vote on an “as-converted” basis with the common stock.  The Series B Preferred Stock automatically converts into the Company’s common stock: (i) upon the affirmative election of the holders of at least a majority of the then outstanding shares of the Series B Preferred Stock voting together as a single class on an as-if-converted to common stock basis; or (ii) if, at the date of exercise in whole or in part of the Warrant, the holder (or holders) of the Series B Preferred Stock own 50.1% of the issued and the Company’s then-outstanding common stock, giving effect to the issuance of shares of common stock in connection with the conversion of the Series B Preferred Stock and such exercise of the Warrant.
	The Warrant entitles, but does not obligate, Scotts Miracle-Gro to purchase a number of shares of common stock that, on a “fully diluted basis” (as defined in the Securities Purchase Agreement), constitute 80% of the Company’s outstanding capital stock (when added to all other shares owned by Scotts Miracle-Gro), as calculated as of the date or dates of exercise.  The Warrant can be exercised at any time and from time to time for a period of five years between April 22, 2016 and April 22, 2021 (the third and eighth anniversary of the closing date).  In addition, the Warrant can be exercised in any increment; there is no obligation to exercise the entire Warrant at one time.  The exercise price of the Warrant shall be equal to the quotient obtained by dividing:
	(a)	an amount equal to (i) 1.34 times the trailing twelve months “Net Sales” (which includes sales of the Company’s products by Scotts Miracle-Gro and its affiliates) minus (ii) “Debt Outstanding” net of cash (as such terms are defined in the Warrant),
	by
	(b)	the total shares of capital stock outstanding, including outstanding in-the-money options and warrants, but not the Warrant contemplated in this Private Offering.
	The Warrant expires on April 22, 2021, the eighth anniversary of the closing date.  The Warrant contains customary anti-dilution rights (for stock splits, stock dividends and sales of substantially all the Company’s assets).  Scotts Miracle-Gro also has the right to participate pro rata, based on Scotts Miracle-Gro’s percentage equity ownership in the Company (assuming the exercise of Scotts Miracle-Gro’s Warrant, but not the exercise of any options outstanding under the Company’s equity compensation plans) in future issuances of the Company’s equity securities.  Upon exercise of the Warrant and demand by Scotts Miracle-Gro, the Company must use its best efforts to file a Registration Statement on Form S-3, or, if the Company is not eligible for Form S-3, on Form S-1 (collectively, the “Registration Statement”), covering the shares of the Company’s common stock covered by the Preferred Stock and the Warrant, within 120 calendar days after receipt of Scotts Miracle-Gro’s demand for registration and shall use its best efforts to cause the Registration Statement to become effective as soon as possible thereafter.
	The Private Offering and sale of the Series B Preferred Stock and Warrant was conducted in reliance upon exemptions from registration requirements under the Securities Act, including, without limitation, those under Regulation D promulgated under the Securities Act.  Scotts Miracle-Gro is an “accredited investor,” as defined in Rule 501 of Regulation D under the Securities Act.  Because the Series B Preferred Stock and the Warrant have not been registered under the Securities Act, they may not be reoffered or resold in the United States absent registration or an applicable exemption from registration.
	The foregoing description of the Securities Purchase Agreement, the Certificates of Designations for the Series B Preferred Stock, the Warrant, and the resulting transaction is only a summary, does not purport to be complete, and is qualified in its entirety by reference to the full text of the applicable documents, each of which was included as an exhibit to the Company’s Current Report on Form 8-K, as filed with the SEC on April 23, 2013. The warrant on the Series B Convertible Preferred Stock was accounted for as a liability at its estimated fair value of $575,854 as of September 30, 2013. The warrant liability will be re-measured to fair value, on a recurring basis, at the end of each reporting period it is exercised or expires. The Company calculated the fair value of the warrants during the quarter ended September 30, 2013 using a multiple based valuation model.
	In conjunction with the “Private Offering” of Series B Preferred Stock and the Warrant above, the Company used $950,000 of the net proceeds to repay “in full” (with concessions) the Main Power Promissory Note.  Main Power also released the Company’s pledged collateral and the parties agreed to terminate the Letter Agreement and Promissory Note effective as of April 22, 2013, as further described in Note 3.  The Company did not incur any early termination penalties. As of April 23, 2013, there was $237,138 in consignment inventory held by Main Power that was fully reserved for during the three month period ended June 30, 2013.
	In conjunction with the Private Offering described above, the Company and Scotts Miracle-Gro also agreed to enter an Intellectual Property Sale Agreement, a Technology License Agreement, a Brand License Agreement, and a Supply Chain Services Agreement.  The Intellectual Property Sale Agreement and the Technology License constitute an agreement of sales of future revenues. Since the Company received cash from Scotts Miracle-Gro and agreed to pay for a defined period a specified percentage of the revenue, and the Company has significant involvement in the generation of the revenue, the excess paid over net book value is classified as debt and is being amortized under the effective interest method.  As of September 30, 2013, $284,206 was recorded as debt on the condensed balance sheets.
	For more details, please refer to Note 8 “Subsequent Events” to the financial statements included in the Company’s Annual Report on Form 10-K, as filed with the SEC on July 1, 2013.

5_Equity_Compensation_Plans

5. Equity Compensation Plans	6 Months Ended
	Sep. 30, 2013
Share-based Arrangements with Employees and Nonemployees [Abstract]	'
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]	'
	5.	Equity Compensation Plans
	On October 17, 2012, a 1-for-100 reverse stock split of AeroGrow’s common stock became effective.  As a result of the reverse stock split, every 100 shares of AeroGrow’s pre-reverse common stock were converted automatically into one share of common stock.  All references below to shares of common stock, common stock warrants, or common stock options have been retroactively adjusted to reflect the reverse stock split.
	For the three months ended September 30, 2013 the Company did not grant options to purchase the Company’s common stock under the Company’s 2005 Equity Compensation Plan (the “2005 Plan”), and for the six months ended September 30, 2013 the Company granted 150,000 options to purchase the Company’s common stock under the 2005 Plan.  For the three and six months ended September 30, 2012, the Company did not grant any options to purchase the Company’s common stock under the 2005 Plan.
	During the three months ended September 30, 2013 there were 31,573 options that were cancelled or that expired, and no shares of common stock were issued upon exercise of outstanding stock options under the 2005 Plan.  During the three months ended September 30, 2012 there were no options that were cancelled or that expired, and no shares of common stock were issued upon exercise of outstanding stock options under the 2005 Plan.
	During the six months ended September 30, 2013 there were 32,020 options that were cancelled or that expired, and no shares of common stock were issued upon exercise of outstanding stock options under the 2005 Plan.  During the six months ended September 30, 2012, there were no options that were cancelled or that expired, and no shares of common stock were issued upon exercise of outstanding stock options under the 2005 Plan.
	As of September 30, 2013, the Company had granted options for 193,095 shares of the Company’s common stock that are unvested and that will result in $137,985 of compensation expense in future periods if fully vested.
	Information regarding all stock options outstanding under the 2005 Plan as of September 30, 2013 is as follows:
			OPTIONS OUTSTANDING							OPTIONS EXERCISABLE
					Weighted-							Weighted-
					average		Weighted-					average		Weighted-
					Remaining		average		Aggregate			Remaining		average		Aggregate
	Exercise				Contractual		Exercise		Intrinsic			Contractual		Exercise		Intrinsic
	price range		Options		Life (years)		Price		Value	Options		Life (years)		Price		Value
	$	1.01		177,149		4.36	$	1.01			59,048		4.36	$	1.01
	$	1.1		100,000		4.5	$	1.1			50,004		4.5	$	1.1
	$	1.21		50,000		4.5	$	1.21			25,002		4.5	$	1.21
	$	7		5,460		2.16	$	7			5,460		2.16	$	7
	$	8		52,910		2.18	$	8			52,910		2.18	$	8
	$	12		1,882		0.85	$	12			1,882		0.85	$	12
	$	13		690		0.86	$	13			690		0.86	$	13
	$	14		1,000		1.73	$	14			1,000		1.73	$	14
	$	18		7,750		0.42	$	18			7,750		0.42	$	18
	$	20		1,040		1.2	$	20			1,040		1.2	$	20
				397,881		3.98	$	2.56	$  288,520		204,786		3.6	$	3.8	$  128,575
	The aggregate intrinsic value in the preceding table represents the difference between the Company’s closing stock price and the exercise price of each in-the-money option on the last trading day of the period presented, which was September 30, 2013.

6_Income_Taxes

6. Income Taxes	6 Months Ended
	Sep. 30, 2013
Income Tax Disclosure [Abstract]	'
Income Tax Disclosure [Text Block]	'
	6.	Income Taxes
	The Company follows the guidance in ASC 740, Accounting for Uncertainty in Income Taxes (“ASC 740”) which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements.  This interpretation defines the minimum recognition threshold a tax position is required to meet before being recognized in the financial statements.
	Deferred income taxes are recognized for the tax consequences in future years of differences between the tax basis of assets and liabilities and their financial reporting amounts at the end of each period, based on enacted laws and statutory rates applicable to the periods in which the differences are expected to affect taxable income.  Any liability for actual taxes to taxing authorities is recorded as income tax liability. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.  A valuation allowance is established against such assets where management is unable to conclude more likely than not that such asset will be realized. As of September 30, 2013 and March 31, 2013, the Company recognized a valuation allowance equal to 100% of the net deferred tax asset balance and the Company has no unrecognized tax benefits related to uncertain tax positions.

7_Related_Party_Transactions

7. Related Party Transactions	6 Months Ended
	Sep. 30, 2013
Related Party Transactions [Abstract]	'
Related Party Transactions Disclosure [Text Block]	'
	7.	Related Party Transactions
	See Note 3. Notes Payable, Long Term Debt and Current Portion – Long Term Debt for disclosure of related party transactions.

8_Stockholders_Equity

8. Stockholders' Equity	6 Months Ended
	Sep. 30, 2013
Stockholders' Equity Note [Abstract]	'
Stockholders' Equity Note Disclosure [Text Block]	'
	8.	Stockholders’ Equity
	On October 17, 2012, a 1-for-100 reverse stock split of AeroGrow’s common stock became effective.  As a result of the reverse stock split, every 100 shares of AeroGrow’s pre-reverse common stock were converted automatically into one share of common stock.  All references below to shares of common stock, common stock warrants, or common stock options have been retroactively adjusted to reflect the reverse stock split.
	A summary of the Company’s common stock warrant activity for the period from April 1, 2013 through September 30, 2013 is presented below:
							Weighted
			Warrants				Average				Aggregate
			Outstanding				Exercise Price				Intrinsic Value
	Outstanding, April 1, 2013			528,258			$	22.41			$	0
	Granted			125,000				1.54
	Exercised			-				-
	Expired			120				0.98
	Outstanding, September 30, 2013			653,138			$	18.38			$	0
	As of September 30, 2013, the Company had the following outstanding warrants to purchase its common stock:
					Weighted Average
	Warrants Outstanding				Exercise Price				Remaining Life (Years)
		125,000			$	1.54				4.56
		394,173			$	7				3.53
		122,600			$	20				1.62
		750			$	25				1.02
		2,750			$	100				0.39
		7,200			$	800				0.93
		665			$	825				0.93
		653,138			$	18.38				3.32
	As discussed further in Note 4, the Company also issued a warrant that entitles, but not obligate Scotts Miracle-Gro to purchase a number of shares of common stock that, on a fully diluted basis, constitute 80% of the Company’s outstanding capital stock (the “SMG Warrant”). The SMG Warrant was accounted for as a liability at its estimated fair value. The warrant liability will be re-measured to fair value at the end of each reporting period until it is exercised or expires.

9_Subsequent_Events

9. Subsequent Events	6 Months Ended
	Sep. 30, 2013
Subsequent Events [Abstract]	'
Subsequent Events [Text Block]	'
	9.	Subsequent Events
	None.

Accounting_Policies_by_Policy_

Accounting Policies, by Policy (Policies)	6 Months Ended
	Sep. 30, 2013
Accounting Policies [Abstract]	'
Use of Estimates, Policy [Policy Text Block]	'
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.  It is reasonably possible that a change in the Company’s estimates will occur in the near term.
Earnings Per Share, Policy [Policy Text Block]	'
	Net Income (Loss) per Share of Common Stock
	The Company computes net income (loss) per share of common stock in accordance with Accounting Standards Codification (“ASC”) 260.  ASC 260 requires companies with complex capital structures to present basic and diluted Earnings per Share (“EPS”).  Basic EPS is measured as the income or loss available to common stockholders divided by the weighted average shares of common stock outstanding for the period. Diluted EPS is similar to basic EPS but presents the dilutive effect on a per share basis of potential common stock (e.g., convertible securities, options, and warrants) as if they had been converted at the beginning of the periods presented. Potential shares of common stock that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS.  All potentially dilutive securities outstanding have been excluded for the periods presented since their effect would be antidilutive.
Reclassification, Policy [Policy Text Block]	'
	Reclassifications
	Certain prior year amounts have been reclassified to conform to current year presentation.
Concentration Risk, Credit Risk, Policy [Policy Text Block]	'
	Concentrations of Risk
	ASC 825-10-50-20 requires disclosure of significant concentrations of credit risk regardless of the degree of such risk.  Financial instruments with significant credit risk include cash deposits.  The amount on deposit with one financial institution exceeded the $250,000 federally insured limit as of September 30, 2013.  However, management believes that the financial institution is financially sound and the risk of loss is minimal.
	Customers:
	For the three months ended September 30, 2013, the Company had two customers, Amazon.com and Canadian Tire Company, that represented 27.0% and 11.6% of sales, respectively.  For the three months ended September 30, 2012, the Company had no customers that represented more than 5.0% of the Company’s net product sales. For the six months ended September 30, 2013, the Company had one customer, Amazon.com, that represented 18.0% of the Company’s net product sales. For the six months ended September 30, 2012, the Company had no customers that represented more than 5.0% of the Company’s net product sales.
	Suppliers:
	For the three months ended September 30, 2013, the Company purchased inventories and other inventory-related items from four suppliers totaling $488,801, $194,153, $64,926 and $43,822, representing 125.8%, 50.0%, 16.7% and 11.3% of cost of revenue, respectively. For the three months ended September 30, 2012, the Company purchased inventories and other inventory-related items from four suppliers totaling $237,690, $137,871, $82,846 and $79,251, representing 43.5%, 25.3%, 15.2% and 14.5% of cost of revenue, respectively. For the six months ended September 30, 2013, the Company purchased inventories and other inventory-related items from four suppliers totaling $530,124, $284,767, $92,659 and $64,926, representing 47.8%, 25.7%, 8.3% and 5.9% of cost of revenue, respectively. For the six months ended September 30, 2012, the Company purchased inventories and other inventory-related items from four suppliers totaling $325,209, $284,045, $137,677, and $118,733, representing 26.2%, 22.9%, 11.1% and 9.6% of cost of revenue, respectively.
	The Company’s primary contract manufacturers are located in China.  As a result, the Company may be subject to political, currency, regulatory and weather/natural disaster risks.  Although the Company believes alternate sources of manufacturing could be obtained, these risks could have an adverse impact on our operations.
	Accounts Receivable:
	As of September 30, 2013, the Company had three customers that represented 66.0%, 10.3% and 5.0% of the Company’s outstanding accounts receivable.  As of March 31, 2013, the Company had one customer who represented 61.2% of outstanding accounts receivable.  The Company believes that all receivables from these customers are collectible.
Fair Value of Financial Instruments, Policy [Policy Text Block]	'
	Fair Value of Financial Instruments
	The Company follows the guidance in ASC 820, Fair Value Measurements and Disclosures (“ASC 820”), as it relates to the fair value of its financial assets and liabilities. ASC 820 provides for a standard definition of fair value to be used in new and existing pronouncements. This guidance requires disclosure of fair value information about certain financial instruments (insurance contracts, real estate, goodwill and taxes are excluded) for which it is practicable to estimate such values, whether or not these instruments are included in the balance sheet at fair value. The fair values presented for certain financial instruments are estimates which, in many cases, may differ significantly from the amounts that could be realized upon immediate liquidation.
	Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability, i.e., exit price, in an orderly transaction between market participants.  ASC 820 also provides a hierarchy for determining fair value, which emphasizes the use of observable market data whenever available. The three broad levels defined by the hierarchy are as follows, with the highest priority given to Level 1 as these are the most reliable, and the lowest priority given to Level 3.
	Level 1 – Quoted prices in active markets for identical assets.
	Level 2 – Quoted prices for similar assets in active markets, quoted prices for identical or similar assets in markets that are not active, or other inputs that are observable or can be corroborated by observable market data, including model-derived valuations.
	Level 3 – Unobservable inputs that are supported by little or no market activity.
	The carrying value of financial instruments including receivables, accounts payable and accrued expenses, approximates their fair value at September 30, 2013 and March 31, 2013 due to the relatively short-term nature of these instruments. As of September 30, 2013 and March 31, 2013, the fair value of the Company's debt, notes payable, and sale of intellectual property liability using Level 3 inputs was estimated using the discounted cash flow method, which is based on the future expected cash flows, discounted to their present values, using a discount rate of 15%.
	In conjunction with the Securities Purchase Agreement and strategic alliance Scotts Miracle-Gro, the Company issued a warrant that entitles, but does not obligate, Scotts Miracle-Gro to purchase a number of shares of common stock that, on a fully diluted basis, constitute 80% of the Company’s outstanding capital stock. This warrant was accounted for as a liability at its estimated fair value. The Company calculated the fair value of the warrant during the quarter ended September 30, 2013 using a multiple based valuation model.
		30-Sep-13				31-Mar-13
		Fair Value		Carry Value		Fair Value		Carry Value
	Liabilities
	Notes payable	$	295,616	$	376,619	$	610,417	$	640,373
	Sale of Intellectual Property Liability		182,023		284,206		--		--
	Warrant Liability		575,854		575,854		--		--
	Long-term debt		183,542		191,937		1,725,513		2,068,110
	Total	$	1,237,035	$	1,428,616	$	2,335,930	$	2,708,483
	As of September 30, 2013, the Company measured the warrant at fair value and will continue to do so on a recurring basis subsequent to initial recognition. As of March 31, 2013, the Company did not have any financial assets or liabilities that were measured at fair value on a recurring basis subsequent to initial recognition.
Receivables, Policy [Policy Text Block]	'
	Accounts Receivable and Allowance for Doubtful Accounts
	The Company sells its products to retailers and consumers. Consumer transactions are primarily paid by credit card.  Retailer sales terms vary by customer, but generally range from net 30 days to net 90 days.  Accounts receivable are reported at net realizable value and net of the allowance for doubtful accounts. The Company uses the allowance method to account for uncollectible accounts receivable. The Company's allowance estimate is based on a review of the current status of trade accounts receivable, which resulted in an allowance of $3,505 and $1,100 at September 30, 2013 and March 31, 2013, respectively.
	Other Receivables
	In conjunction with the Company’s processing of credit card transactions for its direct-to-consumer sales activities and as security with respect to the Company’s performance for credit card refunds and charge backs, the Company is required to maintain a cash reserve with Litle and Company, the Company’s credit card processor. This reserve is equal to 5% of the credit card sales processed during the previous six months. As of September 30, 2013 and March 31, 2013, the balance in this reserve account was $57,943 and $168,511, respectively.
Advertising Costs, Policy [Policy Text Block]	'
	Inventory
	Inventories are valued at the lower of cost, determined by the first-in, first-out method, or market.  Included in inventory costs where the Company is the manufacturer are raw materials, labor, and manufacturing overhead. The Company records the raw materials at delivered cost. Standard labor and manufacturing overhead costs are applied to the finished goods based on normal production capacity as prescribed under ASC 330 Inventory Pricing.  A majority of the Company’s products are manufactured overseas and are recorded at cost.
		September 30,		March 31,
		2013		2013
	Finished goods	$	726,639	$	606,101
	Raw materials		377,549		623,296
		$	1,104,188	$	1,229,397
	The Company determines an inventory obsolescence reserve based on management’s historical experience and establishes reserves against inventory according to the age of the product. As of September 30, 2013 and March 31, 2013, the Company had reserved $331,552 for inventory obsolescence.
Inventory, Policy [Policy Text Block]	'
	Inventory
	Inventories are valued at the lower of cost, determined by the first-in, first-out method, or market.  Included in inventory costs where the Company is the manufacturer are raw materials, labor, and manufacturing overhead. The Company records the raw materials at delivered cost. Standard labor and manufacturing overhead costs are applied to the finished goods based on normal production capacity as prescribed under ASC 330 Inventory Pricing.  A majority of the Company’s products are manufactured overseas and are recorded at cost.
		September 30,		March 31,
		2013		2013
	Finished goods	$	726,639	$	606,101
	Raw materials		377,549		623,296
		$	1,104,188	$	1,229,397
	The Company determines an inventory obsolescence reserve based on management’s historical experience and establishes reserves against inventory according to the age of the product. As of September 30, 2013 and March 31, 2013, the Company had reserved $331,552 for inventory obsolescence.
Revenue Recognition, Policy [Policy Text Block]	'
	Revenue Recognition
	The Company recognizes revenue from product sales, net of estimated returns, when persuasive evidence of a sale exists: that is, a product is shipped under an agreement with a customer; risk of loss and title has passed to the customer; the fee is fixed or determinable; and collection of the resulting receivable is reasonably assured.
	The Company records estimated reductions to revenue for customer and distributor programs and incentive offerings, including promotions, rebates, and other volume-based incentives.  Certain incentive programs require the Company to estimate based on industry experience the number of customers who will actually redeem the incentive. As of September 30, 2013 and March 31, 2013, the Company had accrued $42,880 and $42,623, respectively, as its estimate for the foregoing deductions and allowances.
Standard Product Warranty, Policy [Policy Text Block]	'
	Warranty and Return Reserves
	The Company records warranty liabilities at the time of sale for the estimated costs that may be incurred under its basic warranty program. The specific warranty terms and conditions vary depending upon the product sold but generally include technical support, repair parts, and labor for periods up to one year. Factors that affect the Company’s warranty liability include the number of installed units currently under warranty, historical and anticipated rates of warranty claims on those units, and cost per claim to satisfy the Company’s warranty obligation.  Based upon the foregoing, the Company has recorded a provision for potential future warranty costs of $8,313 and $9,514 as of September 30, 2013 and March 31, 2013, respectively.
	The Company reserves for known and potential returns from customers and associated refunds or credits related to such returns based upon historical experience. In certain cases, retailer customers are provided a fixed allowance, usually in the 1% to 2% range, to cover returned goods and this allowance is deducted from payments made to us by such customers. As of September 30, 2013 and March 31, 2013, the Company has recorded a reserve for customer returns of $10,576 and $27,255, respectively.

2_Liquidity_and_Basis_of_Prese1

2. Liquidity and Basis of Presentation (Tables)	6 Months Ended
	Sep. 30, 2013
Disclosure Text Block [Abstract]	'
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	'In conjunction with the Securities Purchase Agreement and strategic alliance Scotts Miracle-Gro, the Company issued a warrant that entitles, but does not obligate, Scotts Miracle-Gro to purchase a number of shares of common stock that, on a fully diluted basis, constitute 80% of the Company’s outstanding capital stock. This warrant was accounted for as a liability at its estimated fair value. The Company calculated the fair value of the warrant during the quarter ended September 30, 2013 using a multiple based valuation model.
		30-Sep-13				31-Mar-13
		Fair Value		Carry Value		Fair Value		Carry Value
	Liabilities
	Notes payable	$	295,616	$	376,619	$	610,417	$	640,373
	Sale of Intellectual Property Liability		182,023		284,206		--		--
	Warrant Liability		575,854		575,854		--		--
	Long-term debt		183,542		191,937		1,725,513		2,068,110
	Total	$	1,237,035	$	1,428,616	$	2,335,930	$	2,708,483
Schedule of Inventory, Current [Table Text Block]	'Inventories are valued at the lower of cost, determined by the first-in, first-out method, or market. Included in inventory costs where the Company is the manufacturer are raw materials, labor, and manufacturing overhead. The Company records the raw materials at delivered cost. Standard labor and manufacturing overhead costs are applied to the finished goods based on normal production capacity as prescribed under ASC 330 Inventory Pricing. A majority of the Company’s products are manufactured overseas and are recorded at cost.
		September 30,		March 31,
		2013		2013
	Finished goods	$	726,639	$	606,101
	Raw materials		377,549		623,296
		$	1,104,188	$	1,229,397

3_Notes_Payable_Long_Term_Debt1

3. Notes Payable, Long Term Debt and Current Portion - Long Term Debt (Tables)	6 Months Ended
	Sep. 30, 2013
Debt Disclosure [Abstract]	'
Schedule of Debt [Table Text Block]	'As of September 30, 2013 and March 31, 2013, the outstanding balance of the Company’s note payable and debt, including accrued interest, is as follows:
		September 30,		March 31,
		2013		2013
	Main Power Promissory Note	$	--	$	1,703,764
	First Western Trust Term Loan		156,557		322,832
	Notes Payable – Credit Card Receipts-Backed Notes		376,620		640,373
	Pawnee Promissory Note		35,379		41,514
	Debt Associated with Scotts Miracle-Gro Transaction  (see Note 4)		860,060		-
	Total Debt		1,428,616		2,708,483
	Less Notes Payable and Current Portion – Long Term Debt		1,428,616		1,539,772
	Long Term Debt	$	--	$	1,168,711

5_Equity_Compensation_Plans_Ta

5. Equity Compensation Plans (Tables)	6 Months Ended
	Sep. 30, 2013
Share-based Arrangements with Employees and Nonemployees [Abstract]	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]	'Information regarding all stock options outstanding under the 2005 Plan as of September 30, 2013 is as follows:
			OPTIONS OUTSTANDING							OPTIONS EXERCISABLE
					Weighted-							Weighted-
					average		Weighted-					average		Weighted-
					Remaining		average		Aggregate			Remaining		average		Aggregate
	Exercise				Contractual		Exercise		Intrinsic			Contractual		Exercise		Intrinsic
	price range		Options		Life (years)		Price		Value	Options		Life (years)		Price		Value
	$	1.01		177,149		4.36	$	1.01			59,048		4.36	$	1.01
	$	1.1		100,000		4.5	$	1.1			50,004		4.5	$	1.1
	$	1.21		50,000		4.5	$	1.21			25,002		4.5	$	1.21
	$	7		5,460		2.16	$	7			5,460		2.16	$	7
	$	8		52,910		2.18	$	8			52,910		2.18	$	8
	$	12		1,882		0.85	$	12			1,882		0.85	$	12
	$	13		690		0.86	$	13			690		0.86	$	13
	$	14		1,000		1.73	$	14			1,000		1.73	$	14
	$	18		7,750		0.42	$	18			7,750		0.42	$	18
	$	20		1,040		1.2	$	20			1,040		1.2	$	20
				397,881		3.98	$	2.56	$  288,520		204,786		3.6	$	3.8	$  128,575

8_Stockholders_Equity_Tables

8. Stockholders' Equity (Tables)	6 Months Ended
	Sep. 30, 2013
Stockholders' Equity Note [Abstract]	'
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	'A summary of the Company’s common stock warrant activity for the period from April 1, 2013 through September 30, 2013 is presented below:
							Weighted
			Warrants				Average				Aggregate
			Outstanding				Exercise Price				Intrinsic Value
	Outstanding, April 1, 2013			528,258			$	22.41			$	0
	Granted			125,000				1.54
	Exercised			-				-
	Expired			120				0.98
	Outstanding, September 30, 2013			653,138			$	18.38			$	0
Schedule of Stockholders Equity [Table Text Block]	'As of September 30, 2013, the Company had the following outstanding warrants to purchase its common stock:
					Weighted Average
	Warrants Outstanding				Exercise Price				Remaining Life (Years)
		125,000			$	1.54				4.56
		394,173			$	7				3.53
		122,600			$	20				1.62
		750			$	25				1.02
		2,750			$	100				0.39
		7,200			$	800				0.93
		665			$	825				0.93
		653,138			$	18.38				3.32

2_Liquidity_and_Basis_of_Prese2

2. Liquidity and Basis of Presentation (Details) (USD $)	3 Months Ended		6 Months Ended		12 Months Ended	138 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Mar. 31, 2012	Sep. 30, 2013	Mar. 31, 2013
2. Liquidity and Basis of Presentation (Details) [Line Items]	'	'	'	'	'	'	'
Net Income (Loss) Attributable to Parent	($621,827)	($398,654)	($689,124)	($7,566,462)	'	($76,961,452)	'
Proceeds from Short-term Debt	'	'	'	'	1,600,000	'	'
Restructuring and Related Activities, Description	'	'	'	'	'payment schedule for a $2.1 million note payable to a supplier	'	'
Proceeds from Warrant Exercises	'	'	1,590,000	'	'	'	'
Security Purchase Agreement, Description	'	'	'(i) 2,649,007 shares of Series B Convertible Preferred Stock, par value $0.001 per share (the "Series B Preferred Stock); and (ii) a warrant to purchase shares of our common stock for an aggregate purchase price of $4.0 million	'	'	'	'
Proceeds from Sale of Intangible Assets	'	'	500,000	0	'	'	'
Proceeds from Security Purchase Agreement and Sale of Intellectual Property	'	'	4,500,000	'	'	'	'
Number of financial institutions with deposits in excess of federally insured limit	'	'	1	'	'	'	'
Cash, FDIC Insured Amount	250,000	'	250,000	'	'	250,000	'
Fair Value Inputs, Discount Rate	'	'	15.00%	15.00%	'	'	'
Allowance for Doubtful Accounts Receivable, Current	3,505	'	3,505	'	'	3,505	1,100
Other receivable, reserve percentage of credit card sales	'	'	5.00%	'	'	'	'
Deposits Assets, Current	57,943	'	57,943	'	'	57,943	168,511
Deferred Advertising Costs	1,198	'	1,198	'	'	1,198	3,799
Advertising Expense	42,513	120,260	118,339	290,717	'	'	'
Inventory Valuation Reserves	331,552	'	331,552	'	'	331,552	'
Other Accrued Liabilities	42,880	'	42,880	'	'	42,880	42,623
Provision for Future Warranty Costs	8,313	'	8,313	'	'	8,313	9,514
Major customer 1 [Member] | Customer Concentration Risk [Member] | Sales [Member]	'	'	'	'	'	'	'
2. Liquidity and Basis of Presentation (Details) [Line Items]	'	'	'	'	'	'	'
Concentration Risk, Percentage	27.00%	'	18.00%	'	'	'	'
Major customer 1 [Member] | Credit Concentration Risk [Member] | Accounts Receivable [Member]	'	'	'	'	'	'	'
2. Liquidity and Basis of Presentation (Details) [Line Items]	'	'	'	'	'	'	'
Concentration Risk, Percentage	'	'	66.00%	'	'	'	'
Major customer 2 [Member] | Customer Concentration Risk [Member] | Sales [Member]	'	'	'	'	'	'	'
2. Liquidity and Basis of Presentation (Details) [Line Items]	'	'	'	'	'	'	'
Concentration Risk, Percentage	11.60%	'	'	'	'	'	'
Major customer 2 [Member] | Credit Concentration Risk [Member] | Accounts Receivable [Member]	'	'	'	'	'	'	'
2. Liquidity and Basis of Presentation (Details) [Line Items]	'	'	'	'	'	'	'
Concentration Risk, Percentage	'	'	10.30%	'	'	'	'
Major Supplier 1 [Member] | Supplier Concentration Risk [Member] | Cost of Goods, Total [Member]	'	'	'	'	'	'	'
2. Liquidity and Basis of Presentation (Details) [Line Items]	'	'	'	'	'	'	'
Concentration Risk, Percentage	125.80%	43.50%	47.80%	26.20%	'	'	'
Cost of Goods Sold	488,801	237,690	530,124	325,209	'	'	'
Major Supplier 2 [Member] | Supplier Concentration Risk [Member] | Cost of Goods, Total [Member]	'	'	'	'	'	'	'
2. Liquidity and Basis of Presentation (Details) [Line Items]	'	'	'	'	'	'	'
Concentration Risk, Percentage	50.00%	25.30%	25.70%	22.90%	'	'	'
Cost of Goods Sold	194,153	137,871	284,767	284,045	'	'	'
Major Supplier 3 [Member] | Supplier Concentration Risk [Member] | Cost of Goods, Total [Member]	'	'	'	'	'	'	'
2. Liquidity and Basis of Presentation (Details) [Line Items]	'	'	'	'	'	'	'
Concentration Risk, Percentage	16.70%	15.20%	8.30%	11.10%	'	'	'
Cost of Goods Sold	64,926	82,846	92,659	137,677	'	'	'
Major Supplier 3 [Member] | Credit Concentration Risk [Member] | Accounts Receivable [Member]	'	'	'	'	'	'	'
2. Liquidity and Basis of Presentation (Details) [Line Items]	'	'	'	'	'	'	'
Concentration Risk, Percentage	'	'	5.00%	'	'	'	'
Major Supplier 4 [Member] | Supplier Concentration Risk [Member] | Cost of Goods, Total [Member]	'	'	'	'	'	'	'
2. Liquidity and Basis of Presentation (Details) [Line Items]	'	'	'	'	'	'	'
Concentration Risk, Percentage	11.30%	14.50%	5.90%	9.60%	'	'	'
Cost of Goods Sold	43,822	79,251	64,926	118,733	'	'	'
Customer Concentration Risk [Member] | Sales [Member]	'	'	'	'	'	'	'
2. Liquidity and Basis of Presentation (Details) [Line Items]	'	'	'	'	'	'	'
Number of Major Customers	2	'	1	'	'	'	'
Concentration Risk, Customer	'	'no customers that represented more than 5.0% of the Company's net product sales	'no customers that represented more than 5.0% of the Company's net product sales	'	'	'	'
Customer Concentration Risk [Member] | Accounts Receivable [Member]	'	'	'	'	'	'	'
2. Liquidity and Basis of Presentation (Details) [Line Items]	'	'	'	'	'	'	'
Number of Major Customers	'	'	3	1	'	'	'
Supplier Concentration Risk [Member] | Cost of Goods, Total [Member]	'	'	'	'	'	'	'
2. Liquidity and Basis of Presentation (Details) [Line Items]	'	'	'	'	'	'	'
Number of Suppliers	4	4	4	4	'	'	'
Credit Concentration Risk [Member] | Accounts Receivable [Member]	'	'	'	'	'	'	'
2. Liquidity and Basis of Presentation (Details) [Line Items]	'	'	'	'	'	'	'
Concentration Risk, Percentage	'	'	'	61.20%	'	'	'
Allowance for Sales Returns [Member]	'	'	'	'	'	'	'
2. Liquidity and Basis of Presentation (Details) [Line Items]	'	'	'	'	'	'	'
Customer Refund Liability, Current	$10,576	'	$10,576	'	'	$10,576	$27,255

2_Liquidity_and_Basis_of_Prese3

2. Liquidity and Basis of Presentation (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (USD $)	Sep. 30, 2013	Mar. 31, 2013
Liabilities	'	'
Long-term debt	$1,428,616	$2,708,483
Estimate of Fair Value Measurement [Member]	'	'
Liabilities	'	'
Notes payable	295,616	610,417
Sale of Intellectual Property Liability	182,023	0
Warrant Liability	575,854	0
Long-term debt	183,542	1,725,513
Total	1,237,035	2,335,930
Reported Value Measurement [Member]	'	'
Liabilities	'	'
Notes payable	376,619	640,373
Sale of Intellectual Property Liability	284,206	0
Warrant Liability	575,854	0
Long-term debt	191,937	2,068,110
Total	$1,428,616	$2,708,483

2_Liquidity_and_Basis_of_Prese4

2. Liquidity and Basis of Presentation (Details) - Schedule of Inventory, Current (USD $)	Sep. 30, 2013	Mar. 31, 2013
Schedule of Inventory, Current [Abstract]	'	'
Finished goods	$726,639	$606,101
Raw materials	377,549	623,296
	$1,104,188	$1,229,397

3_Notes_Payable_Long_Term_Debt2

3. Notes Payable, Long Term Debt and Current Portion - Long Term Debt (Details) (USD $)

6 Months Ended

12 Months Ended

6 Months Ended

6 Months Ended

6 Months Ended

12 Months Ended

6 Months Ended

Sep. 30, 2013

Sep. 30, 2012

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Sep. 30, 2013

Mar. 31, 2013

Sep. 30, 2013

Sep. 30, 2013

Mar. 31, 2013

Sep. 30, 2013

Mar. 31, 2013

Mar. 31, 2013

Sep. 30, 2013

Sep. 30, 2013

Mar. 31, 2013

Directors and Officers [Member]

Non-Officer and Non-Director Investors with more than 5% Ownership [Member]

Issued to placement agent [Member]

Investor [Member]

Investor [Member]

Company-referred investors [Member]

Company-referred investors [Member]

Directors and Officers [Member]

Directors and Officers [Member]

Main Power Promissory Note [Member]

Main Power Promissory Note [Member]

Revised Main Power Note [Member]

First Western Trust Term Loan [Member]

First Western Trust Term Loan [Member]

2011 Credit card receipts-backed notes [Member]

2011 Credit card receipts-backed notes [Member]

2012 Credit Card Receipts [Member]

2012 Credit Card Receipts [Member]

Pawnee Promissory Note [Member]

Pawnee Promissory Note [Member]

2012 Credit Card Receipts [Member]

2012 Credit Card Receipts [Member]

2012 Credit Card Receipts [Member]

2011 Credit card receipts-backed notes [Member]

2012 Credit Card Receipts [Member]

2011 Credit card receipts-backed notes [Member]

2012 Credit Card Receipts [Member]

2011 Credit card receipts-backed notes [Member]

2012 Credit Card Receipts [Member]

3. Notes Payable, Long Term Debt and Current Portion - Long Term Debt (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Face Amount

'

'

'

$245,000

$350,000

'

'

'

'

'

'

'

$1,386,041

'

$2,162,046

$1,000,000

'

'

$1,633,776

$1,285,722

'

$116,401

'

Debt Instrument, Interest Rate, Stated Percentage

'

'

'

'

'

'

'

'

'

'

'

'

8.00%

'

8.00%

7.25%

'

'

17.00%

15.00%

'

'

'

Debt Instrument, Periodic Payment, Principal

'

'

'

'

'

'

'

'

'

'

'

'

150,000

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Frequency of Periodic Payment

'

'

'

'

'

'

'

'

'

'

'

'

'monthly

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Maturity Date

'

'

'

'

'

'

'

'

'

'

'

'

30-Jun-11

'

31-May-13

21-May-14

'

'

1-Oct-12

1-Nov-13

'

'

'

Debt Instrument, Repurchase Amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

661,446

'

'

'

'

'

'

'

'

Debt Instrument, Maturity Date, Description

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'extended the final maturity to December 15, 2015

'

'

'

'

'

'

'

'

Debt Instrument, Payment Terms

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'monthly interest payments through the final maturity and principal payments totaling $3,000 during the fourth fiscal quarter of Fiscal 2012, $159,000 during Fiscal 2013, $555,000 during the fiscal year ending March 31, 2014, $725,000 during the fiscal year ending March 31, 2015, and $664,724 during the period April 2015 through December 2015.

'equal monthly payments of principal/interest over the four-year term of the FWTB Term

'

'

'20% of our daily credit card receipts were held in escrow with First Western Trust Bank under an Escrow and Account Control Agreement to fund bi-weekly payments of principal and interest to the investors in the Credit Card Offering

'

'

'(i) December 2011 through April 2012 (aggregate payments for the period of $45,000); (ii) November 2012 through April 2013 (aggregate payments for the period of $45,000); and (iii) November 2013 through March 2014 (aggregate payments for the period of $36,064, which amount will be reduced by $4,500 in the event that all payments due during the term of the Lease Promissory Note are made on a timely basis)

'

Repayments of Long-term Debt

1,159,944

161,009

'

'

'

'

'

'

'

'

'

'

'

'

950,000

'

'

'

'

'

'

'

'

Inventory Valuation Reserves

331,552

'

'

'

'

'

'

'

'

'

'

'

'

'

237,138

'

'

'

'

'

'

'

'

Gains (Losses) on Extinguishment of Debt

488,625

0

'

'

'

'

'

'

'

'

'

'

'

'

488,625

'

'

'

'

'

'

'

'

Debt Instrument, Collateral

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'secured by a lien on our assets

'

'

'backed by a portion of our prospective credit card receipts, (the "2011 Credit Card Notes") and a 1% share of our prospective monthly sales into the network marketing channel for a period of three years following our first sale into the network marketing channel (the "MLM Revenue Share") (collectively, the "2011 Credit Card Offering")

'backed by a portion of the Company's prospective credit card receipts, (the "2012 Credit Card Notes") and 128,573 shares of common stock (collectively, the "2012 Credit Card Offering")

'

'

'

Notes Payable to Bank

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

156,557

'

'

'

'

'

'

'

Debt, consideration

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'comprised $1,477,300 in cash and the conversion of $156,476 in other obligations of the Company, including $61,476 of deferred compensation owed to executive officers

'comprised $1,285,722 in cash

'

'

'

Debt Related Commitment Fees and Debt Issuance Costs

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

46,565

46,128

'

'

'

Debt, sales commission percentage

'

'

'

'

'

'

5.00%

5.00%

3.00%

3.00%

0.00%

0.00%

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Debt, Net of Issuance Costs

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,430,735

1,239,594

'

'

'

Debt, deferred sales commissions, percentage

'

'

'

'

'

'

10.00%

'

6.00%

'

0.00%

'

'

'

'

'

'

'

'

'

'

'

'

Guarantor Obligations, Term

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'severally guaranteed by Jack J. Walker, our Chairman (up to $510,555), J. Michael Wolfe, our Chief Executive Officer (up to $204,222) and H. MacGregor Clarke, our former Chief Financial Officer (up to $102,111)

'

'

'

'

Repayments of Debt

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

340,948

198,406

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period (in Shares)

'

'

'

'

'

12,858

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Terms of Award

'

'

'

'

'

'one share of common stock for every 10 shares issued to investors

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, Other (in Shares)

'

'

'

24,500

35,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Notes payable and related party notes payable

376,620

'

640,373

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

376,620

'

'

Debt Instrument, Interest Rate Terms

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'carries an interest rate of 6% per annum for the first twelve months, and 8% per annum thereafter

'

Debt Instrument, Description

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'In the event of a default in payment, the interest rate would be increased to 15% per annum and Pawnee would have the option to (i) declare the Lease Promissory Note to be immediately payable, or (ii) add the accrued interest to the principal balance.

'

Long-term Debt, Current Maturities

$1,051,997

'

$899,399

'

'

'

'

'

'

'

'

'

$0

$1,703,764

'

$156,557

$322,832

'

'

'

'

$35,379

$41,514

3_Notes_Payable_Long_Term_Debt3

3. Notes Payable, Long Term Debt and Current Portion - Long Term Debt (Details) - Schedule of Debt (USD $)	Sep. 30, 2013	Mar. 31, 2013
3. Notes Payable, Long Term Debt and Current Portion - Long Term Debt (Details) - Schedule of Debt [Line Items]	'	'
Current portion of long-term debt	$1,051,997	$899,399
Total Debt	1,428,616	2,708,483
Less Notes Payable and Current Portion b Long Term Debt	1,428,616	1,539,772
Long Term Debt	0	1,168,711
Notes Payable b Credit Card Receipts-Backed Notes	376,620	640,373
Main Power Promissory Note [Member]	'	'
3. Notes Payable, Long Term Debt and Current Portion - Long Term Debt (Details) - Schedule of Debt [Line Items]	'	'
Current portion of long-term debt	0	1,703,764
First Western Trust Term Loan [Member]	'	'
3. Notes Payable, Long Term Debt and Current Portion - Long Term Debt (Details) - Schedule of Debt [Line Items]	'	'
Current portion of long-term debt	156,557	322,832
Pawnee Promissory Note [Member]	'	'
3. Notes Payable, Long Term Debt and Current Portion - Long Term Debt (Details) - Schedule of Debt [Line Items]	'	'
Current portion of long-term debt	35,379	41,514
Scotts Miracle-Gro Company [Member]	'	'
3. Notes Payable, Long Term Debt and Current Portion - Long Term Debt (Details) - Schedule of Debt [Line Items]	'	'
Current portion of long-term debt	$860,060	$0

4_Scotts_MiracleGro_Transactio1

4. Scotts Miracle-Gro Transactions - Convertible Preferred Stock, Warrants and Other Transactions (Details) (USD $)	6 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Mar. 31, 2013
4. Scotts Miracle-Gro Transactions - Convertible Preferred Stock, Warrants and Other Transactions (Details) [Line Items]	'	'	'
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)	$0.00	'	$0.00
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)	1.54	'	'
Class of Warrant or Rights, Exercise Price, Description	'issued a warrant that entitles, but not obligate Scotts Miracle-Gro to purchase a number of shares of common stock that, on a fully diluted basis, constitute 80% of the Company's outstanding capital stock (the "SMG Warrant").	'	'
Fair Value Adjustment of Warrants	$107,500	$0	'
Fair Value Inputs, Discount Rate	15.00%	15.00%	'
Scotts Miracle-Gro Company [Member] | Series B Preferred Stock [Member]	'	'	'
4. Scotts Miracle-Gro Transactions - Convertible Preferred Stock, Warrants and Other Transactions (Details) [Line Items]	'	'	'
Stock Issued During Period, Shares, New Issues (in Shares)	2,649,007	'	'
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)	$0.00	'	'
Stock Issued During Period, Value, New Issues	4,000,000	'	'
Proceeds from Issuance of Convertible Preferred Stock	3,842,685	'	'
Repayments of Debt	950,000	'	'
Convertible Preferred Stock, Shares Issued upon Conversion (in Shares)	2,649,007	'	'
Preferred Stock, Conversion Basis	'$4,000,000 divided by a conversion price of $1.51 per share	'	'
Preferred Stock, Dividend Rate, Percentage	8.00%	'	'
Convertible Preferred Stock, Terms of Conversion	'(i) upon the affirmative election of the holders of at least a majority of the then outstanding shares of the Series B Preferred Stock voting together as a single class on an as-if-converted to common stock basis; or (ii) if, at the date of exercise in whole or in part of the Warrant, the holder (or holders) of the Series B Preferred Stock own 50.1% of the issued and the Company's then-outstanding common stock, giving effect to the issuance of shares of common stock in connection with the conversion of the Series B Preferred Stock and such exercise of the Warrant	'	'
Class of Warrant or Rights, Exercise of Warrant Description	'The Warrant entitles, but does not obligate, Scotts Miracle-Gro to purchase a number of shares of common stock that, on a "fully diluted basis" (as defined in the Securities Purchase Agreement), constitute 80% of the Company's outstanding capital stock (when added to all other shares owned by Scotts Miracle-Gro), as calculated as of the date or dates of exercise.The Warrant can be exercised at any time and from time to time for a period of five years between April 22, 2016 and April 22, 2021 (the third and eighth anniversary of the closing date).In addition, the Warrant can be exercised in any increment; there is no obligation to exercise the entire Warrant at one time.The exercise price of the Warrant shall be equal to the quotient obtained by dividing:(a) an amount equal to (i) 1.34 times the trailing twelve months "Net Sales" (which includes sales of the Company's products by Scotts Miracle-Gro and its affiliates) minus (ii) "Debt Outstanding" net of cash (as such terms are defined in the Warrant),by(b) the total shares of capital stock outstanding, including outstanding in-the-money options and warrants, but not the Warrant contemplated in this Private Offering.	'	'
Derivative Liability	575,854	'	'
Scotts Miracle-Gro Company [Member] | Placement Agent for Securities Purchase Agreement [Member]	'	'	'
4. Scotts Miracle-Gro Transactions - Convertible Preferred Stock, Warrants and Other Transactions (Details) [Line Items]	'	'	'
Class of Warrant or Rights, Granted (in Shares)	125,000	'	'
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)	1.54	'	'
Class of Warrant or Rights, Exercise Price, Description	'125% of the average closing price of the Company's common stock during the five-day period prior to the April 22, 2013 closing date	'	'
Fair Value Adjustment of Warrants	$107,500	'	'
Share Price (in Dollars per share)	$1.30	'	'
Fair Value Assumptions, Expected Term	'3 years	'	'
Fair Value Assumptions, Expected Volatility Rate	117.20%	'	'
Fair Value Inputs, Discount Rate	0.39%	'	'

5_Equity_Compensation_Plans_De

5. Equity Compensation Plans (Details) (USD $)	12 Months Ended	3 Months Ended	6 Months Ended
	Mar. 31, 2013	Sep. 30, 2013	Sep. 30, 2013
		Equity Compensation Plan (2005 Plan) [Member]	Equity Compensation Plan (2005 Plan) [Member]
5. Equity Compensation Plans (Details) [Line Items]	'	'	'
Stockholders' Equity, Reverse Stock Split	'1-for-100	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	'	150,000	32,020
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period	'	31,573	0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares	'	193,095	193,095
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized (in Dollars)	'	$137,985	$137,985

5_Equity_Compensation_Plans_De1

5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable (USD $)	6 Months Ended
	Sep. 30, 2013
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]	'
OPTIONS OUTSTANDING - Options (in Shares)	397,881
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	'3 years 357 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$2.56
OPTIONS OUTSTANDING - Aggregate Intrinsic Value (in Dollars)	$288,520
OPTIONS EXERCISABLE - Options (in Shares)	204,786
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	'3 years 219 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$3.80
OPTIONS EXERCISABLE - Aggregate Intrinsic Value (in Dollars)	$128,575
Options Exercise Price $1.01 [Member]	'
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]	'
Exercise Price Range	$1.01
OPTIONS OUTSTANDING - Options (in Shares)	177,149
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	'4 years 131 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$1.01
OPTIONS EXERCISABLE - Options (in Shares)	59,048
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	'4 years 131 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$1.01
Option Exercise Price $1.10 [Member]	'
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]	'
Exercise Price Range	$1.10
OPTIONS OUTSTANDING - Options (in Shares)	100,000
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	'4 years 6 months
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$1.10
OPTIONS EXERCISABLE - Options (in Shares)	50,004
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	'4 years 6 months
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$1.10
Option Exercise Price $1.21 [Member]	'
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]	'
Exercise Price Range	$1.21
OPTIONS OUTSTANDING - Options (in Shares)	50,000
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	'4 years 6 months
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$1.21
OPTIONS EXERCISABLE - Options (in Shares)	25,002
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	'4 years 6 months
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$1.21
Options Exercise Price $7.00 [Member]	'
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]	'
Exercise Price Range	$7
OPTIONS OUTSTANDING - Options (in Shares)	5,460
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	'2 years 58 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$7
OPTIONS EXERCISABLE - Options (in Shares)	5,460
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	'2 years 58 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$7
Options Exercise Price $8.00 [Member]	'
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]	'
Exercise Price Range	$8
OPTIONS OUTSTANDING - Options (in Shares)	52,910
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	'2 years 65 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$8
OPTIONS EXERCISABLE - Options (in Shares)	52,910
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	'2 years 65 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$8
Options Exercise Price $12.00 [Member]	'
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]	'
Exercise Price Range	$12
OPTIONS OUTSTANDING - Options (in Shares)	1,882
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	'310 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$12
OPTIONS EXERCISABLE - Options (in Shares)	1,882
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	'310 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$12
Options Exercise Price $13.00 [Member]	'
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]	'
Exercise Price Range	$13
OPTIONS OUTSTANDING - Options (in Shares)	690
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	'313 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$13
OPTIONS EXERCISABLE - Options (in Shares)	690
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	'313 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$13
Options Exercise Price $14.00 [Member]	'
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]	'
Exercise Price Range	$14
OPTIONS OUTSTANDING - Options (in Shares)	1,000
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	'1 year 266 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$14
OPTIONS EXERCISABLE - Options (in Shares)	1,000
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	'1 year 266 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$14
Options Exercise Price $18.00 [Member]	'
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]	'
Exercise Price Range	$18
OPTIONS OUTSTANDING - Options (in Shares)	7,750
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	'153 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$18
OPTIONS EXERCISABLE - Options (in Shares)	7,750
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	'153 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$18
Options Exercise Price $20.00 [Member]	'
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]	'
Exercise Price Range	$20
OPTIONS OUTSTANDING - Options (in Shares)	1,040
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	'1 year 73 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$20
OPTIONS EXERCISABLE - Options (in Shares)	1,040
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	'1 year 73 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$20

6_Income_Taxes_Details

6. Income Taxes (Details)	Sep. 30, 2013
Income Tax Disclosure [Abstract]	'
Valuation allowance, percentage	100.00%

8_Stockholders_Equity_Details

8. Stockholders' Equity (Details)	6 Months Ended	12 Months Ended
	Sep. 30, 2013	Mar. 31, 2013
Stockholders' Equity Note [Abstract]	'	'
Stockholders' Equity, Reverse Stock Split	'	'1-for-100
Class of Warrant or Rights, Exercise Price, Description	'issued a warrant that entitles, but not obligate Scotts Miracle-Gro to purchase a number of shares of common stock that, on a fully diluted basis, constitute 80% of the Company's outstanding capital stock (the "SMG Warrant").	'

8_Stockholders_Equity_Details_

8. Stockholders' Equity (Details) - Schedule of Stockholders' Equity Note, Warrants or Rights (USD $)	Sep. 30, 2013	Sep. 30, 2013	Sep. 30, 2013	Sep. 30, 2013	Mar. 31, 2013
		Warrants outstanding [Member]	Weighted average exercise price [Member]	Aggregate Intrinsic Value [Member]	Aggregate Intrinsic Value [Member]
Class of Warrant or Right [Line Items]	'	'	'	'	'
Outstanding, April 1, 2013	653,138	528,258	'	'	'
Outstanding, April 1, 2013 (in Dollars per share)	$18.38	'	$22.41	'	'
Outstanding, April 1, 2013 (in Dollars)	$288,520	'	'	$0	$0
Granted	'	125,000	'	'	'
Granted (in Dollars per share)	'	'	$1.54	'	'
Exercised	'	0	'	'	'
Exercised (in Dollars per share)	'	'	$0	'	'
Expired	'	120	'	'	'
Expired (in Dollars per share)	'	'	$0.98	'	'
Outstanding, September 30, 2013	653,138	653,138	'	'	'
Outstanding, September 30, 2013 (in Dollars per share)	$18.38	'	$18.38	'	'
Outstanding, September 30, 2013 (in Dollars)	$288,520	'	'	$0	$0

8_Stockholders_Equity_Details_1

8. Stockholders' Equity (Details) - Schedule of Warrants Outstanding (USD $)	6 Months Ended
	Sep. 30, 2013
8. Stockholders' Equity (Details) - Schedule of Warrants Outstanding [Line Items]	'
Warrants Outstanding	653,138
Weighted Average Exercise Price (in Dollars per share)	$18.38
Weighted Average Remaing Life (Yrs)	'3 years 116 days
Warrants exercisable at $1.54 [Member]	'
8. Stockholders' Equity (Details) - Schedule of Warrants Outstanding [Line Items]	'
Warrants Outstanding	125,000
Weighted Average Exercise Price (in Dollars per share)	$1.54
Weighted Average Remaing Life (Yrs)	'4 years 204 days
Warrants Exercisable at $7.00 [Member]	'
8. Stockholders' Equity (Details) - Schedule of Warrants Outstanding [Line Items]	'
Warrants Outstanding	394,173
Weighted Average Exercise Price (in Dollars per share)	$7
Weighted Average Remaing Life (Yrs)	'3 years 193 days
Warrants exercisable at $20.00 [Member]	'
8. Stockholders' Equity (Details) - Schedule of Warrants Outstanding [Line Items]	'
Warrants Outstanding	122,600
Weighted Average Exercise Price (in Dollars per share)	$20
Weighted Average Remaing Life (Yrs)	'1 year 226 days
Warrants Exercisable at $25.00 [Member]	'
8. Stockholders' Equity (Details) - Schedule of Warrants Outstanding [Line Items]	'
Warrants Outstanding	750
Weighted Average Exercise Price (in Dollars per share)	$25
Weighted Average Remaing Life (Yrs)	'1 year 7 days
Warrants exercisable at $100.00 [Member]	'
8. Stockholders' Equity (Details) - Schedule of Warrants Outstanding [Line Items]	'
Warrants Outstanding	2,750
Weighted Average Exercise Price (in Dollars per share)	$100
Weighted Average Remaing Life (Yrs)	'142 days
Warrants exercisable at $800.00 [Member]	'
8. Stockholders' Equity (Details) - Schedule of Warrants Outstanding [Line Items]	'
Warrants Outstanding	7,200
Weighted Average Exercise Price (in Dollars per share)	$800
Weighted Average Remaing Life (Yrs)	'339 days
Warrants exercisable at $825.00 [Member]	'
8. Stockholders' Equity (Details) - Schedule of Warrants Outstanding [Line Items]	'
Warrants Outstanding	665
Weighted Average Exercise Price (in Dollars per share)	$825
Weighted Average Remaing Life (Yrs)	'339 days